Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.
More than 500 cancer patients have been treated and cured of cancer cases by the Federal Teaching Hospital, Birnin Kebbi. The Chief Medical Director (CMD) of the health facility, Dr. …
A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in renal cell carcinoma with an overexpression of gene TRIM63 could uncover a mutation otherwise undetected, leading…
Over 500 cancer patients, comprising males and females, have been successful treated and discharged at the Federal Teaching Hospital, Birnin Kebbi, in Kebbi State, North-West Nigeria. Hospital’s Chief Medical Director, CMD, Dr. Aliyu Hamza…
Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.
Get latest articles and stories on Business at LatestLY. New Delhi [India], October 29: BD (Becton, Dickinson and Company) India announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai…
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets cancer cells…
Tumor boards are an invaluable tool to share knowledge and ensure optimal treatment for people with cancer. The conversations that occurred in the hallways outside those disease-focused panels, however, prompted Alan Alper Sag, MD, FSIR,…
Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate…
Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients. People with advanced lung or skin cancer who received the vaccine within 100 days…
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer…
An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of various tumor types.